Tazobactam: Clinical Trials

7 trials of Tazobactam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 suspended, 1 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Recruiting 1, Suspended 1, Terminated 1

Follow Tazobactam: new trials by email Literature Review of Tazobactam trials Research Report on Tazobactam

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Extended infusion time of the following beta-lactam: meropenem, Short-term infusion time of the following beta-lactam: meropenem, Extended infusion time of the following beta-lactam: piperacillin/tazobactam - Infection, Sepsis
Phase 4RecruitingSemmelweis University1102026-09-012026-11-06
BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia
Cefepime, Meropenem, or Piperacillin/Tazobactam - Pneumonia
Phase 4TerminatedUniversity of Florida352021-12-172023-12-12
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
Piperacillin and Tazobactam for Injection, Cefepime Injection, Ceftazidime Injection - Febrile Neutropenia
Phase 4CompletedMurdoch Childrens Research Institute552021-11-152026-03-20
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
Meropenem, Ertapenem 1000 MG, Piperacillin, Tazobactam 4-0.5G Solution for Injection - Urinary Tract Infections, Enterobacteriaceae Infections
Phase 4SuspendedUniversidad del Norte1982019-04-012024-12-06
Acute Appendicitis: Active Observation With and Without Antibiotics
Antibiotic treatment (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3)., Active observation - Appendicitis
Phase 4CompletedGöteborg University1262018-05-152022-08-16
Optimal Care of Complicated Appendicitis
Early Appendectomy, Interval Appendectomy, Antibiotics - Appendicitis, Perforated Appendicitis
Phase 4CompletedUniversity of Michigan402017-06-292023-11-28
Study Evaluation Tazocin Intervention
Tazocin (pipercillin/tazobactam) - Bacterial Infections
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer1342007-05-012011-04-15

Conditions studied

Appendicitis (2)  ·  Bacterial Infections (1)  ·  Enterobacteriaceae Infections (1)  ·  Escherichia coli Infections (1)  ·  Febrile Neutropenia (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Pneumonia (1)  ·  Sepsis (1)  ·  Urinary Tract Infections (1)

Sponsors

Göteborg University (1)  ·  Murdoch Childrens Research Institute (1)  ·  Semmelweis University (1)  ·  Universidad del Norte (1)  ·  University of Florida (1)  ·  University of Michigan (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)  ·  Colombia (1)  ·  Hungary (1)  ·  Sweden (1)

Top investigators

Andres F Estupinan Bohorquez, MD (1)  ·  Charles Peloquin (1)  ·  Diego F Viasus Perez, MD. PhD. (1)  ·  Gabrielle Haeusler (1)  ·  Kent Lundholm, Professor (1)  ·  Steven W. Bruch, M.D. (1)